Shiraishi D, Fujiwara Y, Komohara Y, Mizuta H, Takeya M
BPC-157 is a synthetic peptide derived from Body Protection Compound (BPC), a naturally occurring protein in the human stomach
Improper metabolism of it can, though, and if there is an existing cancer prior to therapy it can accelerate growth
Adverse Effects and Long-Term Safety Concerns While GLP-1 receptor agonists have shown significant benefits, their widespread use is limited by potential side effects such as gastrointestinal distress, pancreatitis risk, and concerns over long-term metabolic effects
Normal side effects like mild nausea typically improve within a few weeks of starting treatment, while gastroparesis involves persistent symptoms that may worsen over time
Ketterer B (1986)